Live Breaking News & Updates on Generic Drug User Fee Act

Stay updated with breaking news from Generic drug user fee act. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

IntelGenx Technologies Corp. (PNK:IGXT) Q3 2023 Earnings Call Transcript

Operator: Greetings. Welcome to IntelGenx’s Third Quarter 2023 Financial Results Conference Call. At this time, all participants are in a listen-only mode. ....

Frank Pietrantonio , Gensco Pharma , Dwight Gorham , Andre Godin , Hugh Kelly , Montelukast Versafilm , Stephen Kilmer , Horst Zerbe , Tommy Kenny , Health Canada , Life Sciences , Intelgenx Technologies Corp , Clinical Research , Swedish Research Council , Karolinska University Hospital , Brd Group , Biggest Renewable Energy Companies In Europe , Chemo Research , Intelgenx Technologies , Call Transcript November , Third Quarter , Results Conference , Investor Relations , Senior Vice President , General Counsel , Canadian Securities ,

IntelGenx Reports Third Quarter 2023 Financial Results

SAINT LAURENT, Quebec, Nov. 09, 2023 (GLOBE NEWSWIRE) IntelGenx Technologies Corp. (TSX:IGX) (OTCQB:IGXT) (the Company or IntelGenx ) toda. ....

United States , Saint Laurent , Gensco Pharma , Montelukast Verafilm , Andre Godin , Montelukast Versafilm , Stephen Kilmer , Intelgenx Montelukast Versafilm , Intelgenx Corp , Exchange Commission , Chemo Research , Tilray Brands Inc , Life Sciences , Securities Exchange , Drug Administration , Company Or Intelgenx , Karolinska University Hospital , Pharma Corporation , Intelgenx Technologies Corp , Genx Technologies , Quarter Financial Summary , Recent Developments , Tilray Brands , Per Svenningsson , Buprenorphine Buccal , Generic Drug User Fee Act ,

IntelGenx Provides Regulatory Update for Xiromed-Partnered Development Candidate, Buprenorphine Buccal Film

SAINT LAURENT, Quebec, Sept. 19, 2023 IntelGenx Corp. today provided a regulatory update on Buprenorphine Buccal Film, for which an abbreviated new drug application has been filed with the. ....

Saint Laurent , United States , Andre Godin , Insud Pharma , Intelgenx Versafilm , Stephen Kilmer , Dwight Gorham , Exchange Commission , Drug Administration , Chemo Research , Securities Exchange , Intelgenx Corp , Company Or Intelgenx , Intelgenx Technologies Corp , Buprenorphine Buccal Film , Complete Response Letter , Amendment Acknowledgement , Generic Drug User Fee Act , Buccal Film , Florham Park , Looking Information , Securities Exchange Act , Securities Act , United States Securities , Intelgenx Technologies ,

IntelGenx Announces Organizational Changes to Support Global Growth Strategy

SAINT LAURENT, Quebec, April 13, 2023 IntelGenx Technologies Corp. today announced various changes to its management team. Following the planned retirement of its founder and CEO, Horst. | April 13, 2023 ....

Saint Laurent , United States , David Kideckel , Tommy Kenny , Horstg Zerbe , Stephen Kilmer , Andre Godin , Karen Kalayajian , Dwight Gorham , Kideckel Advisory Group Inc , Company Or Intelgenx , Corporate Services , Drug Administration , Counsel Of Intelgenx Corp , Chemo Research , Accucaps Industries Ltd , Burroughs Wellcome Co , Exchange Commission , Alexion Pharmaceuticals Inc , Head Of Corporate Development , Legal Affairs , Pharma Inc , Baker Cummings Ltd , Intelgenx Corp , Health Beauty , Merck Co ,

Not Quite the Titanic: The Food and Drug Omnibus Reform Act Rescues Some FDA Policy Initiatives | King & Spalding

The Food and Drug Administration (“FDA” or the “Agency”) user fee negotiations may have hit an iceberg, but it did not sink all the legislative riders that accompanied this summer’s. ....

Seeferdous Al Faruque , Eva Temkin , Public Health Service Act , King Spalding , Senate Bill Client Alert , Drug Administration Safety , Approval Council , Senate Unveils Its Draft , European Union Mutual Recognition Agreement , Rothenberg Educational Center Inc , Agency Record , House Or Senate Bills , Drug Administration , Depomed Inc , House Energy , Senate Bills , Dietary Supplement Health , Catalyst Pharms Inc , Us Dept Of Health Human Servs , Consolidated Appropriations Act , Drug Omnibus Reform Act , Client Alerts , Prescription Drug User Fee Act , Medical Device User Fee Act , Generic Drug User Fee Act , Biosimilar User Fee Act ,